Please login to the form below

Not currently logged in
Email:
Password:

tenofovir

This page shows the latest tenofovir news and features for those working in and with pharma, biotech and healthcare.

Gilead’s COVID-19 drug Veklury brought in almost $2bn in Q4

Gilead’s COVID-19 drug Veklury brought in almost $2bn in Q4

Gilead has attributed the Q4 decrease to lower sales of its Truvada (emtricitabine/tenofovir)-based products, given that the company lost exclusivity of Truvada and Atripla in the US in October

Latest news

More from news
Approximately 9 fully matching, plus 97 partially matching documents found.

Latest Intelligence

  • Choices, choices: the rapidly evolving HIV treatment landscape Choices, choices: the rapidly evolving HIV treatment landscape

    With Triumeq signalling the approval of the first STR without tenofovir disoproxil fumarate (TDF) it can, uniquely, be used in those patients with impaired kidney function. ... Gilead, in hot pursuit, is in phase III of development of a new regimen where

  • Pharma deals during July 2012 Pharma deals during July 2012

    Merck has licensed CMX 157 an oral nucleoside reverse transcriptase inhibitor for treatment of HIV that is 200-fold more potent in vitro than tenofovir (Gilead's product with sales of

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics